Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study

Main Article Content

Elisa Borsani
Luigi Fabrizio Rodella
Elisabetta Sorbellini
Rita Rezzani
Daniela Pinto
Barbara Marzani
Giovanna Tabellini
Mariangela Rucco
Fabio Rinaldi*

Abstract

Regenerative medicine is a modern approach of dermatological treatment, using Epidermal Cells of the interfollicular epidermis (ESCs) for their effect in skin regeneration in chronic ulcers and burns, melanoma, vitiligo, junctional epidermolysis bullosa. Intraepidermal injections of autologous epidermal cell suspension can be a new and very promising treatment for many other cutaneous disorders as non-scarring alopecia (Alopecia Areata, Androgenic Alopecia) or scarring alopecia (Lichern Plano Pilaris alopecia, Discoid Lupus Erithematosus alopecia), anti-aging therapies. The intraepidermal injection of an autologous epidermal cell suspension is a simple, fast and safe surgical procedure: a small, thin portion of the epidermis of the patient undergoes a treatment where a suspension with all the cells collected from the epidermis and cultured for 7 days is injected into the skin. Our preliminary study shows that a suspension contains a significant number of viable cells that survive at day 7 in culture.


Our research is ongoing and is focusing on the typing of the different cells in the suspension and evaluation of the presence and the nature of stem cells.

Article Details

Borsani, E., Rodella, L. F., Sorbellini, E., Rezzani, R., Pinto, D., Marzani, B., … Rinaldi, F. (2017). Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study. Journal of Stem Cell Therapy and Transplantation, 1(1), 066–070. https://doi.org/10.29328/journal.jsctt.1001007
Research Articles

Copyright (c) 2017 Borsani E, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Journal of Stem Cell Therapy and Transplantation is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.

License: Copyright © 2017 - 2025 | Creative Commons License Open Access by Journal of Stem Cell Therapy and Transplantation is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.

With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.

Compliance 'CC BY' license helps in:

Permission to read and download
Permission to display in a repository
Permission to translate
Commercial uses of manuscript

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license. 

Jackson CJ, Tønseth KA, Utheim TP. Cultured epidermal stem cells in regenerative medicine. Stem Cell Res Ther. 2017; 8: 155. Ref: https://goo.gl/x7nfCo

University of Chicago. Chemotherapy plus peripheral stem cell transplantation in treating patients with melanoma or metastatic kidney cancer. ClinicalTrials.gov. 2014; NCT00004135.

Hoerter JD, Bradley P, Casillas A, Chambers D, Weiswasser B, et al. Does melanoma begin in a melanocyte stem cell? J Skin Cancer. 2012. Ref: https://goo.gl/hxe7af

Ann & Robert H Lurie Children’s Hospital of Chicago. Immunoablative mini transplant (hematopoietic peripheral blood stem cell transplant [HPBSC]). ClinicalTrials.gov. 2014; NCT00179764. Ref: https://goo.gl/xzTavg

Fred Hutchinson Cancer Research Center. Combination chemotherapy, total-body irradiation, peripheral stem cell transplantation, and lymphocyte infusion in treating patients with Stage IV melanoma. ClinicalTrials.gov 2011; NCT00006233. Ref: https://goo.gl/RAzGH2

Khodadadi L, Shafieyan S, Sotoudeh M, Dizaj AV, Shahverdi A, et al. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo. Arch Dermatol Res. 2010; 302: 593-599. Ref: https://goo.gl/PCCV95

Van Geel N, Ongenae K, Naeyaert JM. Surgical techniques for vitiligo: a review. Dermatology. 2001; 202: 162-166. Ref: https://goo.gl/QJCLm9

Lee DY, Lee JH. Epidermal grafting for vitiligo: a comparison of cultured and noncultured grafts. Clin Exp Dermatol. 2010; 35: 325-326. Ref: https://goo.gl/WMpBw6

Guerra L, Capurro S, Melchi F, Primavera G, Bondanza S, et al. Treatment of "stable" vitiligo by Timedsurgery and transplantation of cultured epidermal autografts. Arch Dermatol. 2000; 136: 1380-1389. Ref: https://goo.gl/BZqtQk

Matsuzaki K, Kumagai N. Treatment of vitiligo with autologous cultured keratinocytes in 27 cases. Eur J Plast Surg. 2013; 36: 651-656. Ref: https://goo.gl/SWQegA

Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006; 12: 1397-1402. Ref: https://goo.gl/3rabfK

Trink A, Sorbellini E, Bezzola P, Rodella L, Rezzani R, et al. A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol. 2013; 169: 690-694. Ref: https://goo.gl/8uhusp

Allen TD, Potten CS. Fine-structural identification and organization of the epidermal proliferative unit. J Cell Sci. 1974; 15: 291-319. Ref: https://goo.gl/G1e472

Ghazizadeh S, Taichman LB. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. The EMBO Journal. 2001; 20: 1215-1222. Ref: https://goo.gl/t4wVRJ

Purba TS, Haslam IS, Poblet E, Jiménez F, Gandarillas A, et al. Human epithelial hair follicle stem cells and their progeny: current state of knowledge, the widening gap in translational research and future challenges. Bioassays. 2014; 36: 513-525. Ref: https://goo.gl/4Vte5v

Gottipamula S, Saraswat SK, Sridhar KN. Comparative study of isolation, expansion and characterization of epithelial cells. Cytotherapy. 2017; 19: 263-271. Ref: https://goo.gl/CYY5kc

De Kock J, Rodrigues RM, Buyl K, Vanhaecke T, Rogiers V. Human Skin-Derived Precursor Cells: Isolation, Expansion, and Hepatic Differentiation. Methods Mol Biol. 2015; 1250: 113-122. Ref: https://goo.gl/9qhxvg

Fujimori Y, Izumi K, Feinberg SE, Marcelo CL. Isolation of small-sized human epidermal progenitor/stem cells by Gravity Assisted Cell Sorting (GACS). J Dermatol Sci. 2009; 56: 181-187. Ref: https://goo.gl/cAawnP

Kaviani M, Geramizadeh B, Rahsaz M, Marzban S. Considerations in the improvement of human epidermal keratinocyte culture in vitro. Exp Clin Transplant. 2015; 13: 366-370. Ref: https://goo.gl/BY7Gsu

Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA. 1998; 95: 3902-3907. Ref: https://goo.gl/A6EEhY